A novel platelet risk score for stratifing the tumor immunophenotypes, treatment responses and prognosis in bladder carcinoma: results from real-world cohorts

Background: Although the durable efficacy of immune checkpoint inhibitors (ICIs) in BLCA has been confirmed in numerous studies, not all patients benefit from their application in the clinic. Platelets are increasingly being found to be closely associated with cancer progression and metastasis; howe...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Dingshan, Li, Xiaowen, Qi, Tiezheng, Dai, Yuanqing, Liu, Neng, Li, Huihuang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10192868/
https://www.ncbi.nlm.nih.gov/pubmed/37214475
http://dx.doi.org/10.3389/fphar.2023.1187700

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10192868/
https://www.ncbi.nlm.nih.gov/pubmed/37214475
http://dx.doi.org/10.3389/fphar.2023.1187700

Ejemplares similares